Abstract
This chapter illustrates how two common missing data mechanisms (missing completely at random, and missing at random) influence the Type I familywise error rate of the therapeutic window of a drug using multiple test procedures. A therapeutic window is determined by the minimum dose needed to effectively treat a condition or ailment, and the maximum dose that can be safely administered. The effect of multiple imputation procedures for these missing data mechanisms is also assessed. Simulation results suggest that multiple imputations reduce the familywise error rate of the therapeutic window in the presence of missing data.
Keywords and phrases
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Little, R. J. A. and Rubin, D. B. (1987). Statistical Analysis with Missing Data, John Wiley & Sons, New York.
Schafer, J. L. (1997). Analysis of Incomplete Multivariate Data, Chapman and Hall, London.
Shekelle, P. G., Hardy, M. L., Maglione, M., Morton S. C. (2003). Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis, Journal of the American Medical Association, 289, 1537–1545.
Tamhane, A. C. and Logan, B. R. (2002). Multiple test procedures for indentifying the minimum effective and maximum safe doses of a drug, Journal of the American Statistical Association, 97, 293–301.
Tamhane, A. C., Hochberg, Y., Dunnett, C. W. (1996). Multiple test procedures for dose finding, Biometrics, 52, 21–37.
Tamhane, A. C., Dunnett, C. W., Green, J. W., Wetherington, J. F. (2001). Multiple test procedures for identifying the maximum safe dose, Journal of the American Statistical Association, 96, 835–843.
Thall, P. F. and Cheng, S. C. (1999). Treatment comparisons based on two dimensional safety and efficacy alternatives in oncology trials, Biometrics, 55, 746–753.
United States Food and Drug Administration. (2003). Ephedra and Ephedrine for Weight Loss and Atheletic Performance Enhancement: Clinical Efficacy and Side Effects. Report Number 76. U.S. Department of Health and Human Services. Agency for Healthcare Research and Quality.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Birkhäuser Boston
About this chapter
Cite this chapter
Indurkhya, A. (2005). Impact of Missing Data and Imputation Methods on Multiple Test Procedures. In: Balakrishnan, N., Nagaraja, H.N., Kannan, N. (eds) Advances in Ranking and Selection, Multiple Comparisons, and Reliability. Statistics for Industry and Technology. Birkhäuser Boston. https://doi.org/10.1007/0-8176-4422-9_11
Download citation
DOI: https://doi.org/10.1007/0-8176-4422-9_11
Publisher Name: Birkhäuser Boston
Print ISBN: 978-0-8176-3232-8
Online ISBN: 978-0-8176-4422-2
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)